Cannara Biotech Inc (LOVE) — Capital Reinvestment Ratio
Latest as of November 2025:
0.58x
Cannara Biotech Inc (LOVE) has a Capital Reinvestment Ratio of 0.58x as of November 2025, meaning it reinvests 1% of its operating cash flow (CA$7.96 Million) in capital expenditures (CA$4.62 Million). See Cannara Biotech Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.58x
Capex / Operating Cash Flow
Operating Cash Flow
CA$7.96 Million
CAD
Capital Expenditures
CA$4.62 Million
CAD
Data as of
Nov 2025
Most recent filing
Cannara Biotech Inc Capital Reinvestment Ratio (2023–2025)
This chart tracks Cannara Biotech Inc's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Cannara Biotech Inc (2023–2025)
Year-by-year Capital Reinvestment Ratio for Cannara Biotech Inc from 2023 to 2025. For live market cap and broader valuation context, see Cannara Biotech Inc market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.32x | CA$20.01 Million | CA$6.36 Million | ▼ -54.6% |
| 2024 | 0.70x | CA$10.68 Million | CA$7.47 Million | ▼ -58.2% |
| 2023 | 1.67x | CA$5.91 Million | CA$9.88 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow